Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial

UPGRADE

Advanced search

Watchlist | Portfolio | Dashboard

Antares Pharma (ATRS)

N/A x N/A N/A x N/A

Post-market by (Cboe BZX)

5.59 unch (unch) 05/23/22 [NASDAQ]

N/A x N/A N/A x N/A

Post-market 5.59 unch (unch) -

Balance Sheet for Mon, May 23rd, 2022

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	03-2022	12-2021	09-2021	06-2021	03-2021
Assets
Current Assets
Cash & Cash Equivalents	61,715	65,913	57,365	45,126	55,652
Marketable Securities	498	1,245	N/A	N/A	N/A
Receivables	84,137	83,008	54,471	54,224	42,940
Inventories	11,591	11,544	16,493	18,644	19,614
Other current assets	9,142	8,030	2,942	5,725	10,960
TOTAL	$171,585	$174,272	$133,433	$127,963	$133,518

Non-Current Assets
PPE Net	25,727	26,015	25,832	25,590	24,276
Intangibles	18,785	18,974	7,072	7,280	7,488
Other Non-Current Assets	39,561	38,244	50,402	51,786	53,175
TOTAL	$84,073	$83,233	$83,306	$84,656	$84,939

Total Assets	$255,658	$257,505	$216,739	$212,619	$218,457

Liabilities
Current Liabilities
Short Term Debt	1,500	1,500	2,918	22,813	26,260
Accounts payable and accrued liabilities	19,878	17,056	12,885	15,797	16,764
Accrued Expenses	30,216	35,043	32,010	29,655	26,373
TOTAL	$55,729	$58,930	$52,534	$71,975	$72,144

Non-Current Liabilities
Long Term Debt	17,891	18,241	18,401	3,338	14,765
Deferred Revenues	3,100	4,427	3,804	2,675	1,570
aiOther Non-Current Liabilities	5,063	4,576	4,976	5,278	5,323
TOTAL	$24,161	$22,817	$23,377	$8,616	$20,088

Total Liabilities	$79,890	$81,747	$75,911	$80,591	$92,232

Shareholders' Equity
Shares Outstanding, K	170,852	170,106	170,043	169,968	168,798
Common Shares	1,706	1,701	1,700	1,696	1,688
Retained earnings	-178,658	-176,337	-209,020	-214,413	-218,833
Other shareholders' equity	-686	-685	-686	-686	-693
TOTAL	$175,768	$175,758	$140,828	$132,028	$126,225

Total Liabilities And Equity	$255,658	$257,505	$216,739	$212,619	$218,457